Helse Sør-øst RHF
Group Leader combined with Professor II/ Associate Professor of Medicine (Molecular Cell Biology) – Department of Molecular Biology/ Institute of Clinical Medicine
A tenured Group Leader position in molecular cell biology in cancer research is available at the Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital. For qualified candidates a Professor II/ Associate Professor (20 %) position in medicine (Molecular Cell Biology) will be available at Division of Cancer Medicine (KRE),Institute of Clinical Medicine (Klinmed), University of Oslo (UiO).
The mission of the Department of Molecular Cell Biology is to uncover molecular and cellular pathways that distinguish cancer cells from normal cells, with the aim of using this information for patient stratification and development of novel therapies. Three of the groups (led by Harald Stenmark, Tor Erik Rusten and Jorrit Enserink) are members of a Norwegian Centre of Excellence, the Centre for Cancer Cell Reprogramming (CanCell). The aim of this centre is to identify Achilles’ heels of cancers and to target these in order to reprogram cancer cells into harmless cells. CanCell is led by Harald Stenmark, who is also the head of Department of Molecular Cell Biology.
Institute for Cancer Research (ICR)
ICR conducts cutting edge cancer research ranging from basic cancer biology to translational and clinical research. It is the leading cancer research institute in Norway, and has a strong international standing. We are located in a dedicated new building at the Radium Hospital campus of OUH with approximately 350 employees and an annual output of approximately 230 peer reviewed publications. ICR is organized in 6 research departments that currently consist of 25 research groups. Particularly strong research areas are molecular genetics, cell biology, cancer progression and metastasis biology, biomarker discovery and development, radiation biology, tumour immunology/immunotherapy and systems biology. Furthermore, the groups conduct particularly strong translational research within breast cancer, colorectal cancer, lung cancer, lymphomas, sarcomas, melanoma, gynaecologic cancers and prostate cancer. This is supplemented by a department for core facilities including NGS/genomics platforms, bioinformatics, flow- and mass cytometry, pre-clinical imaging (including animal MRI) and electron-, confocal- and high resolution microscopy. In collaboration with the University of Oslo (UiO) ICR is in the leadership of a Center of Excellence (CanCell), a K.G. Jebsen Center for B cell malignancies, and the newly formed Centre for Clinical Cancer Research, MATRIX, as well as other large nation-wide collaborative projects such as for precision cancer medicine and cell-gene therapy and EU-funded projects.
Oslo University Hospital is a workplace with great diversity. We believe this is absolutely crucial to solving the tasks required of us. We therefore want this diversity to be reflected among the applicants for our positions and encourage everyone to apply regardless of who you are and what background you have.
The successful candidate should have a solid foundation in molecular cell biology in cancer research. She/he must document the ability to work independently and an openness to work in highly collaborative teams. The candidate should present a clear future research strategy and will be expected to develop and leverage academic collaborations within the institute as well as externally. Candidates with the strongest scientific production and who have already obtained funding for their research will be preferred, but junior applicants with potential in these directions are also invited to apply. The position is vacant for employment from July 2022.
For qualified candidates, an adjunct (part-time) position as Professor will be available. The main position and the part time position will be combined. It is a requirement that the position holder attends to both positions, and if the main position is left, the part time position must also be vacated. If one is granted leave from the main position, the decision of whether the part time UiO position can be held will be evaluated by the Head of Institute. The 20% position at Klinmed is highly integrated with the full position at the ICR. The position holder will perform research, supervise, teach, and advise at UiO for approximately 20% of her/his time. She/he will be part of the staff at Klinmed and share such duties as required.
- PhD degree in biochemistry, molecular biology, cell biology or related fields with relevance for cancer research
- Documented scientific qualifications at or near the professorial level
- Documented success in obtaining substantial research grants from national and international sources
- Experience with and willingness to build own research group and generate and report on own funding
- Experience from advanced molecular cell biology research, including generation of transgenic and knockout models in cells or model organisms
- Experience from supervision at the MSc and PhD level
- Teaching skills and teaching experience
- Strong national and international network of collaborators
The candidate should be a team player with excellent communication, leadership and organization skills.
The application should be accompanied by a cover letter summarizing the career and past research and innovation portfolio, CV and list of publications with the 10 most significant indicated and a research plan (max 5 pages) for the first 5 years. The applicant is expected to present a plan on how his/her research will integrate and synergize with the ongoing research of the three research groups at the department and with the environment at the ICR, CanCell and at OUH Comprehensive Cancer Centre at large.
Copies of diplomas and references should be available upon request. An external selection committee will evaluate the submissions, and the short-listed candidates will be invited for interview and to present their research plans.
Vi tilbyr:The successful candidate will be offered a permanent position internally funded by OUH. The researcher position will according to Norwegian legislation be subjected to a 6 month probationary period. The position is included in the Norwegian Health Assurance and Retirement Pension Schemes, and the salary will be within the official range at OUH for Group Leader positions depending on qualifications.
Regarding the part-time academic position at UiO:
For a complete job description with qualification requirements and basis of evaluation on the academic position, please see: Description of position
Applications for the academic part-time position must include:
- Cover letter and CV
- Complete list of publications
- Separate list of 10 most relevant publications to be evaluated specifically for the position (please send these publications attached in full text versions).
- Overview of experience in supervising PhD candidates, including names of the candidates, period of supervision, information on institutions and dates for the presentation of the theses, as well as specific information regarding experience as main- or co-supervisor for each candidate, Overview of PhD candidate supervision
- Description of qualifications regarding administration, leadership, teaching and foreign language skills
- Educational portfolio of 3-6 pages documenting educational competence and experience, including a reflection note in which your own practice and learning vision is anchored in the SoTL criteria (focus on student learning, development over time, a research approach and a collegial attitude and practice)
- Other relevant qualifications
See guidelines for designing the application, information for applicants, rules for appointments to Associate/Adjunct Professorships as well as rules concerning pedagogical skills: Application procedures - Faculty of Medicine (uio.no)
Enquiries about the application process related to the part-time position should be directed to Human Resources Advisor at the Institute of Clinical Medicine, Thoril Kristiansen, firstname.lastname@example.org, tlf. +47 22 84 46 99.
For additional information please contact Head of Department of Molecular Cell Biology, Harald Stenmark (email@example.com).
The application should be submitted electronically via WebCuiter.
Head of the Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital combined with an adjunct full Professor position (20%), University of Oslo
Helse Sør-øst RHF
Helse Sør-øst RHF
Senior Researcher combined with Professor II/associate professor in Medicine
Helse Sør-øst RHF
Helse Sør-øst RHF
Helse Sør-øst RHF